Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even better) a broad range of viruses—whatever comes along, in other words. Must be impervious to viral attempts ...
Apr 22, 2026
0
3
Lab-created "frankenproteins" developed by a team of scientists at the University of Toronto Mississauga offer hope for safer and more effective cancer treatments in the future. The protein-based drugs being developed by ...
Apr 22, 2026
0
5
People with a history of psychosis often also have attention-deficit/hyperactivity disorder (ADHD). However, treating this condition presents doctors with a clinical dilemma: Psychostimulants are considered effective for ...
Apr 22, 2026
0
9
A study published in Rheumatology & Autoimmunity challenges the assumption that achieving clinical remission in rheumatoid arthritis is sufficient, showing that patient-reported outcomes vary significantly by drug class even ...
Apr 22, 2026
0
2
Kratom is a plant with psychoactive properties that, when taken at high doses, can produce effects similar to opioids. A new study published in Addiction has found that kratom use—measured as kratom exposures reported to ...
Apr 22, 2026
0
15
The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking behaviors, says the American College of Physicians (ACP). In a new policy, "Reforming 340B to Promote ...
Apr 21, 2026
0
4
The University of Tasmania's Menzies Institute for Medical Research has found that the commonly prescribed medication, Diacerein, does not improve knee osteoarthritis symptoms, following a national study. Diacerein, a medication ...
Apr 21, 2026
0
134
How is it possible to spend tens of billions of dollars developing drugs to treat a serious disease that affects millions of people, and yet end up with something that does not work? This is a mystery that has bedeviled Alzheimer's ...
Apr 21, 2026
0
13
What began as research aimed at expanding the limited treatment options for cystinuria, a rare genetic disorder affecting 1 in every 7,000 people, characterized by the recurrent formation of cystine stones in the kidneys ...
Apr 21, 2026
0
6
Researchers at VIB, VUB, and KU Leuven have identified a tiny binding site, a molecular "keyhole," in the TRPM3 ion channel, a crucial sensor in pain signaling. TRPM3 is also linked to rare neurodevelopmental disorders and ...
Apr 21, 2026
0
4
